FDA Adverse Event Injury Summary report: N

FARADRIVE STEERABLE SHEATH CLEAR

MDR report key: 23469481 · Received November 4, 2025

Report

Report Number
2124215-2025-78659
Event Type
Injury
Date Received
November 4, 2025
Date of Event
June 24, 2025
Report Date
December 2, 2025
Manufacturer
BOSTON SCIENTIFIC CORPORATION
Product Code
DRA
UDI-DI
00191506043131
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

B5: DESCRIBE EVENT OR PROBLEM - UPDATED.

Additional Manufacturer Narrative · 0

IT WAS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION. IF THERE IS ANY FURTHER RELEVANT INFORMATION OBTAINED, A SUPPLEMENTAL MEDWATCH WILL BE FILED.

Description of Event or Problem · 0

DURING AN ATRIAL FIBRILLATION ABLATION PROCEDURE, A FARADRIVE STEERABLE SHEATH CLEAR WAS SELECTED FOR USE. APPROXIMATELY TEN MINUTES FOLLOWING DISCHARGE, THE PATIENT EXPERIENCED MODERATE BLEEDING DUE TO REOPENING OF THE LEFT GROIN ACCESS SITE. THE PATIENT PRESENTED TO MSM EMERGENCY DEPARTMENT AND WAS DISCHARGED WITH A HEMOSTATIC WOUND AND NO SIGNS OF HEMATOMA. THE DEVICE IS NOT EXPECTED TO BE RETURN DUE TO DISPOSAL. ADDITIONAL INFORMATION REVEALED THE PATIENT EXPERIENCED A SMALL GROIN BLEED AND IT RESOLVED SPONTANEOUSLY WITHOUT ANY MEDICAL INTERVENTION

Description of Event or Problem · 0

DURING AN ATRIAL FIBRILLATION ABLATION PROCEDURE, A FARADRIVE STEERABLE SHEATH CLEAR WAS SELECTED FOR USE. APPROXIMATELY TEN MINUTES FOLLOWING DISCHARGE, THE PATIENT EXPERIENCED MODERATE BLEEDING DUE TO REOPENING OF THE LEFT GROIN ACCESS SITE. THE PATIENT PRESENTED TO MSM EMERGENCY DEPARTMENT AND WAS DISCHARGED WITH A HEMOSTATIC WOUND AND NO SIGNS OF HEMATOMA. THE DEVICE IS NOT EXPECTED TO BE RETURN DUE TO DISPOSAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1841958 FARADRIVE STEERABLE SHEATH CLEAR VASCULAR GUIDE-CATHETER, SINGLE-USE DRA BOSTON SCIENTIFIC CORPORATION CL13992 00191506043131

Patients

Seq Age Sex Outcome Treatment
1 68 YR Female Other